Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L A Moye

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
The American Journal of Cardiology|January 16, 1990
The Cardiac Arrhythmia Suppression Trial: background, interim results and implicationsC M Pratt, L A Moye
Alternative Therapies in Health and Medicine|May 11, 1999
Coley toxins immunotherapy: a retrospective reviewM A Richardson, T Ramirez, N C Russell, et al.
Critical Care Medicine|April 1, 1985
Predictability and consequences of spontaneous extubation in a pediatric ICUP H Scott, H Eigen, L A Moye, et al.
JAMA|September 27, 2001
Low-density lipoprotein size, pravastatin treatment, and coronary eventsH Campos, L A Moye, S P Glasser, et al.
Alternative Therapies in Health and Medicine|September 1, 1997
Coping, life attitudes, and immune responses to imagery and group support after breast cancer treatmentM A Richardson, J Post-White, E A Grimm, et al.
Circulation|October 18, 2000
VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trialF M Sacks, P Alaupovic, L A Moye, et al.
Circulation|September 17, 1998
Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) InvestigatorsP M Ridker, N Rifai, M A Pfeffer, et al.
American Heart Journal|March 20, 1998
Absence of a deleterious effect of calcium channel blockers in patients with left ventricular dysfunction after myocardial infarction: The SAVE Study Experience. SAVE Investigators. Survival and Ventricular EnlargementW D Hager, B R Davis, A Riba, et al.
Journal of the American College of Cardiology|July 21, 1998
Effect of pravastatin on cardiovascular events in women after myocardial infarction: the cholesterol and recurrent events (CARE) trialS J Lewis, F M Sacks, J S Mitchell, et al.
Annals of Internal Medicine|December 5, 1998
Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range. Results of the Cholesterol and Recurrent Events (CARE) trialS J Lewis, L A Moye, F M Sacks, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
The American Journal of Cardiology|January 16, 1990
The Cardiac Arrhythmia Suppression Trial: background, interim results and implicationsC M Pratt, L A Moye
Alternative Therapies in Health and Medicine|May 11, 1999
Coley toxins immunotherapy: a retrospective reviewM A Richardson, T Ramirez, N C Russell, et al.
Critical Care Medicine|April 1, 1985
Predictability and consequences of spontaneous extubation in a pediatric ICUP H Scott, H Eigen, L A Moye, et al.
JAMA|September 27, 2001
Low-density lipoprotein size, pravastatin treatment, and coronary eventsH Campos, L A Moye, S P Glasser, et al.
Alternative Therapies in Health and Medicine|September 1, 1997
Coping, life attitudes, and immune responses to imagery and group support after breast cancer treatmentM A Richardson, J Post-White, E A Grimm, et al.
Circulation|October 18, 2000
VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trialF M Sacks, P Alaupovic, L A Moye, et al.
Circulation|September 17, 1998
Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) InvestigatorsP M Ridker, N Rifai, M A Pfeffer, et al.
American Heart Journal|March 20, 1998
Absence of a deleterious effect of calcium channel blockers in patients with left ventricular dysfunction after myocardial infarction: The SAVE Study Experience. SAVE Investigators. Survival and Ventricular EnlargementW D Hager, B R Davis, A Riba, et al.
Journal of the American College of Cardiology|July 21, 1998
Effect of pravastatin on cardiovascular events in women after myocardial infarction: the cholesterol and recurrent events (CARE) trialS J Lewis, F M Sacks, J S Mitchell, et al.
Annals of Internal Medicine|December 5, 1998
Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range. Results of the Cholesterol and Recurrent Events (CARE) trialS J Lewis, L A Moye, F M Sacks, et al.
Pageof 2